TRACking health behaviors in people with Multiple Sclerosis (TRAC-MS) : Study protocol and description of the study sample
© 2022 Published by Elsevier Inc..
Introduction: People with multiple sclerosis (PwMS) experience a range of physical, cognitive, and affective symptoms. Behavioral interventions targeting increased physical activity show promising support as low-cost methods to improve working memory, episodic memory, and processing speed in PwMS. In this randomized controlled trial, we will examine the efficacy of a pedometer-tracking intervention, designed to increase low-to-moderate levels of physical activity, for improving working memory in PwMS.
Methods and Analysis: Eighty-seven PwMS, between the ages of 30-59, have been recruited for the study. Seventy-five of the eligible and interested individuals were randomized to six-month health behavior monitoring groups: a Step-track group or a Water-track group (serving as the active control). Neuropsychological measures, assessing the primary outcome of the study, were administered at pre, midpoint, and post-intervention. Exploratory factor analysis of neuropsychological measures resulted in three factors: a working memory/processing speed factor, a visual episodic memory factor, and a verbal episodic memory factor. Changes in this latent measure of working memory/processing speed is the primary outcome of the current study. Functional MRI data will be analyzed to examine changes in the functional connectivity of the neural network supporting working memory.
Ethics and dissemination: The institutional review board granted approval for the study and all participants provided written informed consent. The results of this study will provide support showing that step-tracking increases overall levels of physical activity, improves working memory and processing speed, and strengthens the neural circuitry that supports better cognition. Evidence from this study will thus offer promising support for the routine use of step-tracking devices to improve cognitive functioning in PwMS. Study results will be disseminated through peer-reviewed publications and presentations at scientific conferences.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:30 |
|---|---|
| Enthalten in: |
Contemporary clinical trials communications - 30(2022) vom: 25. Dez., Seite 101006 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Prakash, Ruchika S [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Cognition |
|---|
| Anmerkungen: |
Date Revised 06.01.2023 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1016/j.conctc.2022.101006 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM347192033 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM347192033 | ||
| 003 | DE-627 | ||
| 005 | 20231226033246.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.conctc.2022.101006 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1157.xml |
| 035 | |a (DE-627)NLM347192033 | ||
| 035 | |a (NLM)36203849 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Prakash, Ruchika S |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a TRACking health behaviors in people with Multiple Sclerosis (TRAC-MS) |b Study protocol and description of the study sample |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 06.01.2023 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © 2022 Published by Elsevier Inc. | ||
| 520 | |a Introduction: People with multiple sclerosis (PwMS) experience a range of physical, cognitive, and affective symptoms. Behavioral interventions targeting increased physical activity show promising support as low-cost methods to improve working memory, episodic memory, and processing speed in PwMS. In this randomized controlled trial, we will examine the efficacy of a pedometer-tracking intervention, designed to increase low-to-moderate levels of physical activity, for improving working memory in PwMS | ||
| 520 | |a Methods and Analysis: Eighty-seven PwMS, between the ages of 30-59, have been recruited for the study. Seventy-five of the eligible and interested individuals were randomized to six-month health behavior monitoring groups: a Step-track group or a Water-track group (serving as the active control). Neuropsychological measures, assessing the primary outcome of the study, were administered at pre, midpoint, and post-intervention. Exploratory factor analysis of neuropsychological measures resulted in three factors: a working memory/processing speed factor, a visual episodic memory factor, and a verbal episodic memory factor. Changes in this latent measure of working memory/processing speed is the primary outcome of the current study. Functional MRI data will be analyzed to examine changes in the functional connectivity of the neural network supporting working memory | ||
| 520 | |a Ethics and dissemination: The institutional review board granted approval for the study and all participants provided written informed consent. The results of this study will provide support showing that step-tracking increases overall levels of physical activity, improves working memory and processing speed, and strengthens the neural circuitry that supports better cognition. Evidence from this study will thus offer promising support for the routine use of step-tracking devices to improve cognitive functioning in PwMS. Study results will be disseminated through peer-reviewed publications and presentations at scientific conferences | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Cognition | |
| 650 | 4 | |a Multiple sclerosis | |
| 650 | 4 | |a Pedometer-tracking | |
| 650 | 4 | |a Physical activity | |
| 650 | 4 | |a Randomized controlled trial | |
| 700 | 1 | |a Manglani, Heena R |e verfasserin |4 aut | |
| 700 | 1 | |a Duraney, Elizabeth J |e verfasserin |4 aut | |
| 700 | 1 | |a Shankar, Anita |e verfasserin |4 aut | |
| 700 | 1 | |a Fisher, Megan E |e verfasserin |4 aut | |
| 700 | 1 | |a Janssen, Alisha |e verfasserin |4 aut | |
| 700 | 1 | |a Cea, Lauren |e verfasserin |4 aut | |
| 700 | 1 | |a Petosa, Rick |e verfasserin |4 aut | |
| 700 | 1 | |a Andridge, Rebecca |e verfasserin |4 aut | |
| 700 | 1 | |a Nicholas, Jacqueline |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Contemporary clinical trials communications |d 2015 |g 30(2022) vom: 25. Dez., Seite 101006 |w (DE-627)NLM257485147 |x 2451-8654 |7 nnns |
| 773 | 1 | 8 | |g volume:30 |g year:2022 |g day:25 |g month:12 |g pages:101006 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.conctc.2022.101006 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 30 |j 2022 |b 25 |c 12 |h 101006 | ||